Is Cost-Effectiveness Analysis Unfair?

Abstract

Get full access to this article

View all access options for this article.

References

1. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.

2. Johannesson M. Should we aggregate relative or absolute changes in QALYs? Health Econ. 2001;10:573-577.

3. Nord E. The desirability of a condition versus the well being and worth of a person. Health Econ. 2001;10:579-581.

4. Williams A. The “fair innings argument” deserves a fairer hearing! Comments by Alan Williams on Nord and Joannesson. Health Econ. 2001;10:583-585.

5. Russell LB. Too much for too few: what cost-effectiveness tells us about prevention. In: Skelton WD, Osterweis M, eds. Promoting Community Health: The Role of the Academic Health Center. Washington (DC): Association of Academic Health Centers; 1993.

6. Mandelblatt JS, Fahs MC. The cost-effectiveness of cervical cancer screening for low-income elderly women. JAMA. 1988;259: 2406-2413.

7. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113:214-226.

8. Daniels N, Sabin JE. Setting Limits Fairly. New York: Oxford University Press; 2002.